Thermo fisher scientific to acquire clario holdings, inc., enabling pharma and biotech customers to accelerate innovation with deeper clinical insights

Waltham, mass.--(business wire)--thermo fisher scientific inc. (nyse: tmo), the world leader in serving science, today announced a definitive agreement to acquire clario holdings, inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by astorg and nordic capital, novo holding and cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance. clario integrates clinic.
TMO Ratings Summary
TMO Quant Ranking